[Future prospects for hepatitis C treatment: without interferon and ribavirin?].

Abstract

The hepatitis C virus is an important health problem worldwide. Currently, the standard treatment of genotype 1 chronic hepatitis C is the combination of pegylated interferon, ribavirin and a first-generation protease inhibitor: telaprevir or boceprevir. This triple therapy has improved the efficacy of treatment but has also increased regimen complexity… (More)
DOI: 10.1016/j.gastrohep.2014.01.002

Topics

Cite this paper

@article{Lens2014FuturePF, title={[Future prospects for hepatitis C treatment: without interferon and ribavirin?].}, author={Sabela Lens and Ignacio Jim{\'e}nez Alfaro}, journal={Gastroenterologia y hepatologia}, year={2014}, volume={37 5}, pages={311-21} }